Understanding the problems in pharmaceutical procurement with special reference to active pharmaceutical ingredients and excipients

被引:0
|
作者
Zauwad Alam
Sukhbir Kaur
Pawan Kumar Porwal
机构
[1] ISF College of Pharmacy,Incompatibility Study Division & Analytical Laboratory (ISFAL), Department of Quality Assurance
[2] Amity University Madhya Pradesh,Amity Institute of Pharmacy (AIP)
来源
关键词
Pharmaceutical procurement; Active pharmaceutical ingredient; Regulatory requirements; User requirement specifications; Vendor certification procedure;
D O I
暂无
中图分类号
学科分类号
摘要
Procurement of raw materials, key intermediates and excipients for the preparation of finished pharmaceutical preparation is considered to be complex process which involve multiple channels and require skilled personnel and proper validation. This review attempts, in relatively brief compass to provide an account of the problems that arise while procurement of active pharmaceutical ingredient (API) and excipients in pharmaceutical industry. This review has been structured with specified as well as generalized problems raised up during procurement of API and other material in pharmaceutical industry. Lack of proper regulatory requirements and unbiased market information with the absence of a comprehensive procurement policy is the major factor which creates complications while procurement. Besides these, lack of properly designed user requirement specifications (URS) which ultimately affect quality and delivery of quoted material. An 8-Question-based approach has been proposed to design URS, other approaches for material procurement and supplier qualification have been discussed, and a vendor certification procedure is presented.
引用
收藏
页码:319 / 328
页数:9
相关论文
共 50 条
  • [1] Understanding the problems in pharmaceutical procurement with special reference to active pharmaceutical ingredients and excipients
    Alam, Zauwad
    Kaur, Sukhbir
    Porwal, Pawan Kumar
    ACCREDITATION AND QUALITY ASSURANCE, 2018, 23 (06) : 319 - 328
  • [2] Separation of Active Pharmaceutical Ingredients (APIs) from Excipients in Pharmaceutical Formulations
    Atwood, Jerry L.
    CRYSTAL GROWTH & DESIGN, 2015, 15 (06) : 2874 - 2877
  • [3] Tribo-electrification of active pharmaceutical ingredients and excipients
    Supuk, Enes
    Zarrebini, Afsheen
    Reddy, Jay P.
    Hughes, Helen
    Leane, Michael M.
    Tobyn, Mike J.
    Timmins, Peter
    Ghadiri, Mojtaba
    POWDER TECHNOLOGY, 2012, 217 : 427 - 434
  • [4] From inactive ingredients to pharmaceutical excipients
    Steinberg, M.
    Blecher, L.
    Mercill, A.
    Pharmaceutical Technology, 2001, 25 (07): : 62 - 64
  • [5] Application of instrumented nanoindentation in preformulation studies of pharmaceutical active ingredients and excipients
    Egart, Mateja
    Jankovic, Biljana
    Srcic, Stane
    ACTA PHARMACEUTICA, 2016, 66 (03) : 303 - 330
  • [6] Understanding flow chemistry for the production of active pharmaceutical ingredients
    Burange, Anand S.
    Osman, Sameh M.
    Luque, Rafael
    ISCIENCE, 2022, 25 (03)
  • [7] Medicated ocular bandages and corneal health: potential excipients and active pharmaceutical ingredients
    Zidan, Ghada
    Rupenthal, Ilva D.
    Greene, Carol
    Seyfoddin, Ali
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2018, 23 (03) : 255 - 260
  • [8] Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: Impact on bioequivalence
    Garcia-Arieta, Alfredo
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 65 : 89 - 97
  • [9] Influence of Process Parameters on the Heterogeneous Nucleation of Active Pharmaceutical Ingredients onto Excipients
    Bueno, Raquel Arribas
    Crowley, Clare M.
    Hodnett, Benjamin K.
    Hudson, Sarah
    Davern, Peter
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2017, 21 (04) : 559 - 570
  • [10] Modeling fluidized bed impregnation of active pharmaceutical ingredients onto porous excipients
    Grigorov, Plamen, I
    Muzzio, Fernando J.
    Glasser, Benjamin J.
    CHEMICAL ENGINEERING SCIENCE, 2019, 202 : 36 - 54